Discordance in Hormone Receptor and HER2 Status in Breast Cancer During Tumor Progression


Discordance in Hormone Receptor and HER2 Status in Breast Cancer During Tumor Progression
Slides from a presentation at SABCS 2010 and transcribed comments from Lisa A Carey, MD (12/12/10)

Lindstrom LS et al. Discordance in hormone receptor and HER2 status in breast cancer during tumor progression. San Antonio Breast Cancer Symposium 2010;Abstract S3-5.

Dr Carey is Medical Director of the UNC Breast Center at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina.